Sompharmaceuticals' Acquisition

Sompharmaceuticals was acquired by Amryt on May 13, 2016.

Sompharmaceuticals is a biopharmaceutical company focused on developing novel somatostatin analogue peptide medicines for patients with rare neuroendocrine diseases with high unmet need, principally f…

Articles about Sompharmaceuticals' Acquisition: